An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Investors are eyeing a rebound in the U. biotech sector in 2026, as more companies are expected to go public amid a renewed ...

The SFDA reported that approximately 2,700 patients have benefited from access to innovative and advanced treatments through ...

GEA has teamed up with Bio Factory to deliver a precision and biomass fermentation line at the latter's open-access facility ...

Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...

Calendars obtained by Bay Area News Group show which executives, donors and political heavyweights had direct access to the ...